| Identification | Back Directory | [Name]
3-Pyridinamine, N-[(3S)-1-(3-fluoropropyl)-3-pyrrolidinyl]-6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]- | [CAS]
2735803-90-2 | [Synonyms]
3-Pyridinamine, N-[(3S)-1-(3-fluoropropyl)-3-pyrrolidinyl]-6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]- | [Molecular Formula]
C26H31F4N5 | [MOL File]
2735803-90-2.mol | [Molecular Weight]
489.55 |
| Hazard Information | Back Directory | [Uses]
Estrogen receptor antagonist 2 is a selective estrogen receptor downregulator. Estrogen (E2) and estrogen alpha receptor (ERα) are important drivers of breast cancer development. Estrogen receptor antagonist 2 has the potential for the research of breast cancer diseases (extracted from patent WO2021228210A1, compound 3)[1]. | [References]
[1] Gu Peng, et al. Pyrrolidine compounds and their applications. Patent WO2021228210A1. |
|
|